International Open Access, Peer-reviewed Platform

Our vision is to provide a global platform for open journals to promote qualitative research publications for
Science, Engineering, Technology and Medicine, with an un-restricted access.

Igor Grachev

Designation:
Global Development Leader
Department:
CNS Clinical Development, Movement Disorders
University:
Novartis Consumer Health Inc.
Country:
USA
Email:
grachevi@hotmail.com
Journal Associated: Journal of Neurology, Neurological Science and Disorders Biography:

Research Interest: Clinical trials design & methods, neurobiology of movement and neurodegenerative disorders (Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, and Huntington’s disease), chronic & neuropathic and acute pain, migrain & headacke, obsessive-compulsive disorders and trichotillomania, depression, anxiety, schizophrenia, ADHD, Stroke and applications of Imaging Technologies (PET, mMRI, fMRI, MRS, SPECT etc.) for Drug Development. </xml> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> Clinical trials design & methods, neurobiology of movement and neurodegenerative disorders (Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, and Huntington’s disease), chronic & neuropathic and acute pain, migrain & headacke, obsessive-compulsive disorders and trichotillomania, depression, anxiety, schizophrenia, ADHD, Stroke and applications of Imaging Technologies (PET, mMRI, fMRI, MRS, SPECT etc.) for Drug Developmen